Differential (Click to cross reference) adverse drug reaction algorithm andexanet anticoagulant, complications of anticoagulant, discontinuation anticoagulant, restarting anticoagulant, reversal of anticoagulant, treatment anticoagulation, perioperative apixaban atrial fibrillation, risk stratification cerebrovascular accident cerebrovascular accident, acute management of ciraparantag coagulopathy complications controversies in neurology cost cost effectiveness coumarin coumarin, restarting treatment coumarin, stopping treatment dabigatran edoxaban efficacy endovascular therapy enoxaparin facial nerve palsy factor Xa inhibitor fibrinolytic agents hemorrhagic diathesis hemostatic therapy iatrogenic neurologic disorders idarucizumab INR values intracerebral hemorrhage intracerebral hemorrhage, progression of intracerebral hemorrhage, volume mortality neurologic complications of, surgery non-vitamin K antagonist oral anticoagulants peri-procedural platelet inhibiting drugs postoperative neurologic complications practice guidelines prothrombin complex concentrate reperfusion review article risk stratification rivaroxaban safety thrombectomy thrombolysis, mechanical tissue plasminogen activator, intravenous treatment of neurologic disorder vitamin K

Showing articles 0 to 9 of 9 Perioperative Management of Anticoagulant and Antiplatelet Therapy NEJM Evid doi:10.1056/EVIDna2200322, Douketis,J.D. & Spyropoulos,A.C., 2023 Economic Evaluation of Andexanet Versus Prothrombin Complex Concentrate for Reversal of Factor Xa-Associated Intracranial Hemorrhage Stroke 52:1390-1397, Micieli, A.,et al, 2021 Administering Thrombolysis for Acute Ischemic Stroke in Patients Taking Direct Oral Anticoagulants JAMA Neurol 78:515-518, Seiffge, D.J.,et al, 2021 Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage Stroke 50:529-536, Bower, M.M.,et al, 2019 Management of Bleeding in Patients Taking Oral Anticoagulants JAMA 319:2032-2033, Anderson, I.,et al, 2018 Andexxa-An Antidote for Apixaban and Rivaroxaban JAMA 320:399-400, , 2018 Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents Stroke 48:1432-1437, Steiner, T.,et al, 2017 Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors NEJM 375:1131-1141,1185, Connolly, S.J.,et al, 2016 Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity NEJM 373:2413-2424,2471, Siegal, D.M.,et al, 2015 Showing articles 0 to 9 of 9